# Efficacy and Safety of Intraarticular Injections of Hyalgan in the Treatment of Osteoarthritis of the Knee

> **NCT01319461** · PHASE3 · COMPLETED · sponsor: **Med Pharma Co., Ltd.** · enrollment: 200 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DEVICE:** Hyalgan
- **DEVICE:** sterile normal saline

## Key facts

- **NCT ID:** NCT01319461
- **Lead sponsor:** Med Pharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** 2002-06
- **Final completion:** 2002-06
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2011-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01319461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01319461, "Efficacy and Safety of Intraarticular Injections of Hyalgan in the Treatment of Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01319461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*